STOCK TITAN

OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
earnings

BETHLEHEM, Pa., April 30, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 5, 2021. 

May 5, 2021 Schedule
 
4:01 p.m. ET2021 first quarter financial results press release will be distributed.
  
4:50 p.m. ETTo participate in the conference call, dial 844-831-3030 (Domestic) or 315-625-6887 (International) and reference Conference ID # 1349536
  
5:00 p.m. ETConference call and simultaneous Webcast begins.

The conference call will also be available via webcast, and may be accessed on the Investor Relations page of OraSure’s website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access, 10 minutes prior to the call.

If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for 14 days. A replay of the call can also be accessed until midnight, May 19, 2021 by dialing (855) 859-2056 (Domestic) or (404) 537-3406 (International) and entering the Conference ID # 1349536.

COMPANY CONTACT: Sam Martin, Argot Partners. 212-600-1902, or orasure@argotpartners.com.


Orasure Technologies Inc.

NASDAQ:OSUR

OSUR Rankings

OSUR Latest News

OSUR Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Bethlehem

About OSUR

based in bethlehem, pennsylvania, orasure technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. these products include tests for the detection of antibodies to the hiv virus, including the oraquick® in-home hiv test, oraquick advance® rapid hiv-1/2 antibody test and the orasure® hiv-1 oral specimen collection device, a test for antibodies to the hcv virus, the oraquick® hcv rapid antibody test, and oral fluid testing solutions for drugs of abuse testing, including intercept® oral fluid drug testing system and q.e.d.® saliva alcohol test. orasure also manufactures and sells several leading cryosurgical products. these include: histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product fo